Delivery Order SPE2DB20D3103-SPE2DB25FN5T9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract valued at $3,326.61. The award was made on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,656.68 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packaging). This contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and utilizes firm fixed pricing with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $3,852.25 under a firm fixed-price contract structure. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) with a ceiling value of $5,951.28 under a firm fixed price contract. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,918.34 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.33 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count) on July 29, 2025, with completion scheduled for July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded delivery order has a ceiling value of $3,822.24 and is structured as a firm fixed price contract with an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN5T9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count packages) with a ceiling value of $1,766.91. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen provides pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/24/25 |